APA

Hoogkamp-Korstanje J. A., Dirks-Go S. I., Kabel P., Manson W. L., Stobberingh E. E., Vreede R. W. & Davies B. I. (19970807). Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. : The Journal of antimicrobial chemotherapy.

Chicago

Hoogkamp-Korstanje J A, Dirks-Go S I, Kabel P, Manson W L, Stobberingh E E, Vreede R W and Davies B I. 19970807. Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. : The Journal of antimicrobial chemotherapy.

Harvard

Hoogkamp-Korstanje J. A., Dirks-Go S. I., Kabel P., Manson W. L., Stobberingh E. E., Vreede R. W. and Davies B. I. (19970807). Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. : The Journal of antimicrobial chemotherapy.

MLA

Hoogkamp-Korstanje J A, Dirks-Go S I, Kabel P, Manson W L, Stobberingh E E, Vreede R W and Davies B I. Multicentre in-vitro evaluation of the susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to ciprofloxacin, clarithromycin, co-amoxiclav and sparfloxacin. : The Journal of antimicrobial chemotherapy. 19970807.